1-3 of 3
Mir Alikhan
Close
Sort by
Journal Articles

Predictors of Adverse Clinical Outcome in Diffuse Large B-Cell Lymphoma Richter Transformation of CLL/SLL: A Consortium of Richter Transformation Investigators (CORTI) Multicenter Study across 8 US, UK, and Australian Academic Centers

Emily Symes, Zhihong Hu, Stephen K. Walker, Vishakha Sovani, Nicolas Lopez-Hisijos, Barina Aqil, Mir Alikhan, Claudiu V. Cotta, Sean Harrop, Angela Lager, Beenu Thakral, Peter A. Riedell, Carrie Fitzpatrick, Michael J. Thirman, Anand Ashwin Patel, Caner Saygin, Sandra L. Ondrejka, Michael R. Bishop, Amir Behdad, Sandeep Gurbuxani, Daniel A. Arber, M. James You, Richard A. Larson, Sonali M. Smith, Yan Amber Hodgson, Justin Kline, Matthew Ku, Girish Venkataraman
Journal: Blood
Blood (2022) 140 (Supplement 1): 2053–2055.
https://doi.org/10.1182/blood-2022-155950
Published: 2022
Journal Articles

Burkitt Leukemia Involving Only the Bone Marrow Has a Better Prognosis Than Widespread Burkitt Lymphoma Involving the Bone Marrow in Adults

Joo Y Song, MD, Girish Venkataraman, MD MBBS, Yuri D. Fedoriw, MD, Mir Alikhan, MD, Young Kim, MD, Dennis D. Weisenburger, MD, Joyce Collins, PhD, Xueli Liu, PhD, Amy S. Duffield, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4446.
https://doi.org/10.1182/blood.V124.21.4446.4446
Published: 2014
Journal Articles

Anti-IL6 Antibody (ab) Based Strategies Improve the Management of HIV Negative Castleman’s Disease.

Frits van Rhee, MD, PhD, Mir Alikhan, MD, Nikhil Munshi, MD, PhD, Ron Walker, MD, James Waldron, MD, Guido Tricot, MD, PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3283.
https://doi.org/10.1182/blood.V104.11.3283.3283
Published: 2004